KATHERINE GREENLEE: Open Payments
NPI 1699446674 · SIOUX FALLS, SD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$562 in 18 payments from 12 companies in 2025. Trend: 2023 $300 · 2024 $154 · 2025 $562
Food & beverage: $562
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 2 | $148 |
| Boston Scientific Corporation | 1 | $118 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 5 | $117 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $39 |
| Novartis Pharmaceuticals Corporation | 1 | $24 |
| Novo Nordisk Inc | 1 | $21 |
| Regeneron Healthcare Solutions, Inc. | 1 | $20 |
| Amgen Inc. | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
| Merck Sharp & Dohme LLC | 1 | $16 |
Products named: FABRAZYME, WATCHMAN FLX, LifeVest, Kerendia, LEQVIO, Wegovy, EVKEEZA, REPATHA.
Industry payments across SD — which companies pay providers there.
